跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
張 維倫
Doctor
內科部
電子郵件
weilun1
mail.ncku.edu
tw
h-index
2402
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(104)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Lun Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter pylori
100%
Esophageal Squamous Cell Carcinoma
54%
Chemoradiation Therapy
46%
Reflux Esophagitis
46%
Esomeprazole
28%
Levofloxacin
28%
Peptic Ulcer Bleeding
25%
Esophagus Cancer
25%
Ulcer
25%
Abdominal Cancer
23%
Clarithromycin
20%
Neoplasm
19%
Duodenum Ulcer
18%
Stomach Ulcer
18%
Intestine Metaplasia
16%
Amoxicillin
15%
Comorbidity
15%
Spasmolytic Agent
15%
Pantoprazole
15%
CYP2C19
14%
Infection
14%
Metronidazole
13%
Tumor Growth
13%
Omeprazole
12%
Peptic Ulcer
11%
Jejunum Ulcer
11%
Biological Marker
11%
Overall Survival
10%
Proton Pump Inhibitor
10%
Bleeding
10%
Stomach Acid
9%
Tetracycline
9%
Clinical Trial
9%
Stromelysin
9%
Matrix Metalloproteinase
9%
Blood Stasis
8%
Diseases
8%
Recurrent Disease
8%
Recurrent Peptic Ulcer
8%
Metaplasia
7%
Celecoxib
7%
Amino Acid
7%
Randomized Controlled Trial
7%
Liver Cell Carcinoma
7%
Tranexamic Acid
7%
Polypeptide
7%
Tumor Thrombus
7%
Low Back Pain
7%
Esophagus Fistula
7%
Gemifloxacin
7%
Medicine and Dentistry
Esophageal Squamous Cell Carcinoma
74%
Helicobacter pylori
68%
Chemoradiotherapy
52%
Intestinal Metaplasia
38%
Esophageal Cancer
35%
Chemoradiation Therapy
33%
Endoscopic Ultrasound
30%
Neoplasm
28%
Abdominal Cancer
26%
Treatment Response
21%
Esomeprazole
19%
Peptic Ulcer Bleeding
17%
Recurrent Disease
17%
Recurrent Peptic Ulcer
16%
Osteopontin
15%
Helicobacter Infection
15%
Reflux Esophagitis
15%
Intensity Modulated Radiation Therapy
15%
Adverse Event
14%
Infection
13%
Endoscopy
12%
Jejunum Ulcer
11%
Overall Survival
11%
Tumor Progression
11%
Biological Marker
11%
Computer Assisted Tomography
10%
Stricture
10%
Endoscopic Hemostasis
9%
Radiation Therapy
9%
Clinical Trial
9%
DNA Methylation
8%
Proton-Pump Inhibitor
8%
Ulcer
8%
Omeprazole
8%
Esophagogastroduodenoscopy
7%
Metaplasia
7%
Esophageal Stricture
7%
Meta-Analysis
7%
Gastroesophageal Reflux
7%
Diagnostic Accuracy
7%
Peptide Sequence
7%
Narrow Band Imaging
7%
Learning Curve
7%
Sputum
7%
Celecoxib
7%
Otorhinolaryngology
7%
Fine-Needle Aspiration
7%
Nerve Root
7%
Tranexamic Acid
7%
Randomized Controlled Trial
7%
Keyphrases
Helicobacter Pylori (H. pylori)
30%
Esophageal Squamous Cell Carcinoma
25%
Esophageal Cancer
17%
Yes-associated Protein 1 (YAP1)
15%
Pro-tumor
15%
Negative Regulator
15%
Infected Patients
10%
Spasmolytic Polypeptide-expressing Metaplasia
10%
Radiotherapy Resistance
9%
Duodenal Ulcer
9%
Cancer Patients
8%
Poor Prognosis
8%
Trefoil Factor 2
8%
Gastric Ulcer
8%
Intestinal Metaplasia
7%
Ulcer
7%
Tumor Microenvironment
7%
Taiwan
7%
Peristomal Infection
7%
Response Evaluation
7%
Definitive Chemoradiotherapy (dCRT)
7%
Endoscopic Ultrasound
7%
Hepatocellular Carcinoma
7%
Upper Aerodigestive Tract
7%
White Light Imaging
7%
Endosonography
7%
Tumor Length
7%
Superficial Esophageal Squamous Cell Carcinoma
7%
Advanced Esophageal Squamous Cell Carcinoma
7%
Topical Tranexamic Acid
7%
Narrow Band Imaging
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Primary Tumor Volume
7%
Quadruple Regimen
7%
Antibiotic Selection
7%
Arterio-oesophageal Fistula
7%
Disabled-2 (Dab2)
7%
ITGB1
7%
Polymorphism
7%
DNA Methyltransferase Inhibitor
7%
DupA
7%
Inferior Vena Cava Thrombosis
7%
Ghrelin Level
7%
Los Angeles Classification
7%
EUS-guided
7%
Multi-level Fusion
7%
White Materials
7%
Esophageal mucosa
7%
Cancer Biopsy
7%
CLDN4
7%
